Drew Weissman

Drew Weissman
Drew Weissman
	Weissman in 2022
Born	September 7, 1959; Lexington, Massachusetts, U.S.
Education	Brandeis University (BA, MA); Boston University (MD, PhD);
Known for	Modified mRNA technologies used in COVID-19 vaccines
Awards	Rosenstiel Award (2020); Lasker–DeBakey Clinical Medical Research Award (2021); VinFuture Prize (2022); Breakthrough Prize in Life Sciences (2022); Harvey Prize (2023); Nobel Prize in Physiology or Medicine (2023);
	Scientific career
Institutions	University of Pennsylvania
Thesis	Regulation of B Lymphocytes with Reagents That Cross-Link Surface Immunoglobulin (1987)
Doctoral advisor	Ann Marshak-Rothstein

Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).

Weissman's work underlies the development of mRNA vaccines, the best known of which are those for COVID-19 produced by BioNTech/Pfizer and Moderna. With biochemist Katalin Karikó, Weissman received the Nobel Prize in Physiology or Medicine in 2023 "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19". Weissman has been a recipient and co-recipient of numerous awards, also including the prestigious Lasker–DeBakey Clinical Medical Research Award. In 2022, he was elected to the National Academy of Medicine and the American Academy of Arts and Sciences.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.